---
document_datetime: 2023-09-21 19:23:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/deferiprone-lipomed-epar-all-authorised-presentations_en.pdf
document_name: deferiprone-lipomed-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.713551
conversion_datetime: 2025-12-30 10:52:37.338183
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented)          | Strength   | Pharmaceutical     | Route of   | Immediate                    | Pack size   |
|------------------|---------------------|------------|--------------------|------------|------------------------------|-------------|
| EU/1/18/1310/001 | Deferiprone Lipomed | 500 mg     | Film-coated tablet | Oral use   | Blister (aluminium/PVC/PVDC) | 100 tablets |